PA-BOOMI
Boomi™ , the intelligent connectivity and automation leader, today announced the appointment of Madeline Ling as chief financial officer (CFO), Marcy Campbell as chief revenue officer (CRO), and Fran Wilson as chief marketing officer (CMO), effective immediately. Additionally, Emmy award-winning news journalist Christa Delcamp joins Boomi to support public relations and media strategy, and James Dyson joins the company to lead Global Diversity, Equity, and Inclusion Talent Acquisition.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220613005227/en/
“Boomi's recent launch as a standalone company – coupled with our high growth and cutting-edge, cloud-based technology – provides the opportunity to build our leadership team as part of a much larger expansion, with several hundred new hires coming onboard this year,” said David Meredith, CEO at Boomi. “Our industry-leading platform and award-winning culture enabled us to recruit top, globally-minded talent, with a demonstrated track-record of achievement, and a passion to accelerate our mission to make the world a better place by connecting everyone to everything, anywhere.”
The new leadership appointments come after Boomi's recent independence backed by premier private equity firms, Francisco Partners and TPG, in a $4 billion transaction. As a global software as a service (SaaS) category leader with more than 20,000 customers – Boomi touts a growing user community of over 100,000 members , a worldwide network of more than 800 partners , and one of the largest arrays of global system integrators (GSI) in the iPaaS space, which includes Accenture, Deloitte, SAP, and Snowflake, as well as the three largest cloud providers, Amazon Web Services, Google, and Microsoft, among others.
Boomi has been positioned as a Leader in the Gartner® Magic Quadrant™ for enterprise platform as a service (EiPaaS)1 for eight consecutive years . The company recently received the Gold Globee® Award in the Platform as a Service (PaaS) category, and has garnered numerous awards for being an employer of choice, including a recent listing as one of Inc. Magazine’s Best Workplaces . As the company continues to scale rapidly to meet global, enterprise demand for digital connectivity, integration, and automation, Boomi plans to hire several hundred new team members this year to accelerate all functions of the business.
BOOMI ATTRACTS WORLD-CLASS TALENT:
Madeline Ling, CFO
Ling holds a MBA from Stanford Graduate School of Business, and brings nearly 25 years of experience leading equity-backed, global enterprise organizations through strategic and international growth. She has held multiple CFO roles throughout her career, including international assignments overseas. Ling most recently served as corporate CFO for a Hellman and Friedman (H&F) PE-backed portfolio company, and held previous roles at VMware, The Boston Consulting Group, and Intel.
Marcy Campbell, CRO
Campbell brings to Boomi over 30 years of experience leading large-scale, go-to-market organizations for global companies ranging from Fortune 500 to venture-backed technology firms. She most recently served as senior vice president at PayPal where she led global sales, professional services, and operations. At Boomi, Campbell will spearhead the company’s revenue-generating strategies with a focus on driving fast growth, while continuing to deliver customer value.
Fran Wilson, CMO
With more than 20 years of successful experience in SaaS and B2B enterprise software organizations, Wilson provided marketing leadership through Red Hat’s initial public offering (IPO), and during its rapid revenue growth from $400 million to more than $4 billion, culminating in its sale to IBM for $34 billion.
Christa Delcamp, Public Relations and Media Strategy
Delcamp brings over two decades of experience in public relations, journalism, content creation, and communications, across a variety of platforms, including digital/social, NBC and CBS-owned and operated stations, radio/podcasting, and print. An Emmy award-winning news journalist, Delcamp’s extensive expertise in telling impactful stories will help Boomi increase market awareness of its industry-leading platform and important mission to connect the world.
James Dyson, Global Diversity, Equity, and Inclusion (DE&I) Talent Acquisition
Dyson brings over 20 years of experience leading and managing talent acquisition at global companies, including Accenture. In his role, Dyson will leverage his deep expertise and extensive international network to support Boomi’s rapid growth and continue to build the company’s award-winning culture.
Additional Resources
- Check out open roles at Boomi
- Learn more about the Boomi AtomSphere Platform
- Explore the Boomiverse Community
- Follow Boomi on Twitter , LinkedIn , Facebook , and YouTube
Gartner Disclaimer:
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER and Magic Quadrant are registered trademarks and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Note: Boomi was recognized as Dell Boomi from 2014 to 2019.
About Boomi
Boomi instantly connects everyone to everything, anywhere with its cloud-native, unified, open, and intelligent platform. Boomi's integration platform as a service (iPaaS) is trusted by more than 20,000 customers globally for its speed, ease-of-use, and lower total cost of ownership. As the pioneer at fueling intelligent use of data, Boomi's vision is to make it quick and easy for customers and partners to discover, manage, and orchestrate data, while connecting applications, processes, and people for better, faster outcomes. For more information, visit http://www.boomi.com .
© 2022 Boomi, LP. Boomi, the ‘B’ logo, Boomiverse, and AtomSphere are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
________________________
1
Gartner, Magic Quadrant for Enterprise Integration Platform as a Service, Eric Thoo, Keith Guttridge, Bindi Bhullar, Shameen Pillai, Abhishek Singh, September 29, 2021
View source version on businesswire.com: https://www.businesswire.com/news/home/20220613005227/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lone Star Announces Sale of SPX FLOW to ITT Inc.5.12.2025 13:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced the signing by an affiliate of Lone Star Fund XI, LP of a definitive agreement to sell SPX FLOW, Inc. (“SPX FLOW”), a leading provider of highly engineered equipment and process technologies for attractive end markets including industrial, health and nutrition, to ITT Inc. (NYSE: ITT) for $4.775 billion in cash and shares of common stock. Based in Charlotte, N.C., SPX FLOW focuses on process technologies delivering mixing, blending, fluid handling, separation, thermal heat transfer and other solutions integral to industrial, health and nutrition markets. The company has operations in more than 25 countries and sales in more than 140 countries. In partnership with Lone Star, SPX FLOW has focused on improving its sales execution and operating platform, while ensuring high quality and innovative product development. The management team has improved the company’s commercial organization and executed growth initiatives to build its presence in e
AmTrust Financial Services and Blackstone Credit & Insurance Close Strategic Transaction and Launch Newly Formed Multinational MGACompany Named ANV Group Holdings Ltd.5.12.2025 13:00:00 CET | Press release
Strategic Transaction Unlocks Value for AmTrust and Positions ANV Group Holdings for Accelerated GrowthFormer AmTrust President Adam Karkowsky Leading ANV Group Holdings as Chairman and CEO AmTrust Financial Services, Inc. (“AmTrust” or the “Company”), a global specialty property casualty insurer, and Blackstone Credit & Insurance (“BXCI”), today announced the closing of a strategic transaction under which AmTrust and funds managed by BXCI have partnered to spin-off certain of AmTrust’s Managing General Agencies (“MGAs”) and fee-based businesses in the U.S., United Kingdom, and Continental Europe, into ANV Group Holdings Ltd. (“ANV”), a newly formed independent company, following receipt of regulatory approvals. AmTrust and ANV have entered into a ten-year capacity agreement through which AmTrust will remain the underwriter for the existing books of business offered through the MGAs. As previously announced on September 15, 2025, the agreement includes seven AmTrust subsidiaries: ANV S
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body5.12.2025 07:00:00 CET | Press release
Sculptra®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to include gluteal area, posterior thighs, décolletage, and upper arms1 Studies investigating the efficacy of Sculptra on areas beyond the face show patients experienced progressive improvements in skin quality (including the improvement in cellulite appearance), firmness, lift, projection, and contour Sculptra’s versatility and new indication allow practitioners to shift patient treatment goals beyond rejuvenation toward enhancement, meeting evolving patient needs The certification validates Sculptra’s safety performance, efficacy, and quality, reinforcing Galderma’s commitment to innovation and meeting evolving patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its
Northern Escape Heli-Skiing Takes the Title of “World’s Best Heli-Ski-Operator” for the 4th Year Running5.12.2025 02:40:00 CET | Press release
4x World’s Best Heli-Skiing Operation near Terrace, BC Northern Escape Heli-Skiing (NEH) has been named World’s Best Heli-Ski Operator 2025 by the World Ski Awards, marking its fourth straight victory following years 2022, 2023 and 2024. This recognition places NEH amongst an elite group of ski tourism operators consistently voted best in the world by industry leaders and enthusiasts alike. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204074550/en/ A four-year run built on reliability NEH operates in British Columbia’s Skeena Mountains, where deep northern snow and vast terrain come together with small-group heli-skiing and heli snowboarding. When helicopters can’t safely fly, NEH has cat skiing readily available as a backup — an exceedingly rare offering in this industry. The operation spans over 833,571 wild acres of alpine bowls, glaciers and old-growth tree skiing. The NEH experience Guests choose from three lodge f
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance5.12.2025 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollment in Q1 2026, initially evaluating patients with solid tumors known to express B7H3 and PTK7, including lung, colorectal, head and neck, and ovarian/gynecological cancers. IDE034 is a bispecific B7H3/PTK7 TOP1 ADC, independently developed by Biocytogen and licensed to IDEAYA in July 2024. The IND clearance marks an important milestone for this licensed program, supporting subsequent clinical development of IDE034, while highlighting Biocytogen’s technical capabilities in bispecific ADC discovery and development. Dr. Yue
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom